COVID Moonshot Sprint 5
Sprint 5 to prioritize compounds for the open science patent-free COVID Moonshot drug discovery project has launched! Rev up your GPUs to help develop a new therapy.
Read moreCategory: Folding@home Blog
Could a new class of antibodies treat COVID-19 in a manner that avoids resistance?
Several antibodies are now in clinical trials to both treat and provide protection against COVID-19. But one of these binds in a completely surprising way, and in a manner that may head off viral resistance. How does it work? We’re trying to find out!
Read moreCOVID Moonshot Sprint 4
As the COVID Moonshot continues to make rapid progress, the fourth free energy sprint focused on a backup lead series that suddenly pulls into the lead!
Read moreTogether we are Even More Powerful: GPU folding gets a powerup with NVIDIA CUDA support!
Folding@home adds CUDA support to give NVIDIA GPUs big boosts in speed!
Read moreLaunching the Third Weekly Sprint for the COVID Moonshot!
We’re launching the third weekly compound prioritization sprint for the COVID Moonshot! This sprint focuses on our benzotriazole lead series. These compounds came about from a previous series of potent…
Read moreAn in-depth article with Greg Bowman, the new director of Folding@Home.
Read more in this article from Washington University in St Louis.
Read moreAI for Drug Discovery in Two Stories
TL;DR: Today, we are excited to share two papers that tell distinct stories about AI drug discovery: 1. “Spatial Graph Convolutions for Drug Discovery” describes new deep neural network architectures…
Read moreAndroid client overhaul
  “In October 2017 we announced the open sourcing of the Folding@Home Android client developed by Sony.  We want to thank everyone who have contributed with CPU time. From the 16th…
Read moreUsing F@H to “Drug the Undruggable”
In Project 10490, the Chodera lab is studying a small protein called KRAS, which forms a key link in growth signaling and cancer. This gene is something like a molecular…
Read moreUnderstanding epigenetic cancer targets with Folding@home: Histone methyltransferases NSD1, NSD2, and NSD3
The Chodera Lab at the Memorial Sloan Kettering Cancer Center is now running a series of projects to study the conformational dynamics of histone methyltransferases to aid in the rational design of new small molecule…
Read more